Study at a glance
What question did the studies ask?
How does the placenta take up and change vitamin D compounds? Researchers studied human placentas after delivery, early placental cells and samples from a pregnancy trial.
What did they find?
The placenta took up and changed vitamin D compounds in laboratory experiments. Higher vitamin D3 intake in the pregnancy trial raised 25-hydroxyvitamin D in umbilical-cord blood. This is a form that cells can change into active hormone. The researchers did not detect an overall difference in activity of the five placental genes tested.
What does this mean?
The placenta helps regulate vitamin D locally. A higher blood result, a change in a cell and better fetal health are different outcomes. These studies do not show that increasing maternal vitamin D improves fetal development.
What are the limits?
Some experiments were very small. Labelled active hormone was detected in only one of the placentas tested with labelled compounds. Two reports may share participants. Pregnancy stages, tissue preparations and vitamin D forms differed. The evidence does not establish a personal pregnancy dose or blood target.
Read the full article below ↓The placenta can take up and change vitamin D compounds. This review asks how those processes relate to the mother’s blood supply and the vitamin D reaching the fetus. It compares experiments in human placentas and placental cells with samples from a pregnancy trial. The studies support local regulation, but they do not establish that increasing maternal vitamin D improves fetal development. Read the detailed assessment, Placental Vitamin D Metabolism and Transport: Full Evidence Review.
What was studied?
Most vitamin D blood tests measure 25-hydroxyvitamin D. This is a form that some cells can change into calcitriol, the active hormone. Enzymes are proteins that help chemical reactions happen. Some help produce active vitamin D; others help break down vitamin D compounds. For carrier background, see Vitamin D Transport Proteins.
Researchers kept the blood-vessel pathways working in placentas after delivery and supplied labelled 25-hydroxyvitamin D3, a form that cells can change into active hormone, so they could follow it. Other studies examined early placental cells and how active certain genes were. A pregnancy trial assigned women by chance to different daily amounts of vitamin D3. It measured placental genes and vitamin D in blood from the umbilical cord. The general processing background is Vitamin D Metabolism at the Cellular Level.
What did the studies find?
The experiments in delivered placentas supported uptake, chemical changes and transfer of vitamin D compounds. They were small. Labelled active hormone was detected in one placenta. The findings do not establish how quickly active hormone reaches the fetal side across all samples.
Other experiments showed that a chemical change to DNA could reduce activity of a gene involved in vitamin D breakdown. This does not mean that the placenta cannot break down vitamin D. Some early placental cells moved through a laboratory barrier more readily after exposure to vitamin D compounds. That does not establish better development in pregnancy.
In the GRAVITD trial samples, the higher daily amount of vitamin D3 produced higher 25-hydroxyvitamin D in umbilical-cord blood. The researchers did not detect an overall difference in how active the five measured placental genes were. Gene activity, transport speed and clinical health are different outcomes. For receptor background, without assuming measured gene activity proves a functional response, see Vitamin D Receptors.
What does this mean?
The placenta is an active part of vitamin D handling. However, a higher blood concentration does not prove that a particular transport pathway has improved. A cell response does not prove better fetal health.
What are the main limits?
The studies used different stages of pregnancy, tissue preparations and vitamin D forms. Some experiments were very small. Two reports used potentially overlapping placental samples and should not be treated as fully independent confirmation. The pregnancy trial’s placental samples came from pregnancies selected because they had no major complications of the kinds excluded by the study.
The evidence does not establish an individual pregnancy dose, a blood target or a proven effect on how the mother’s immune system tolerates the fetus. The daily amounts tested describe the research.
Sources
Related reading
Association between maternal vitamin D, calcium, and inflammatory cytokines in Iraqi pregnant women with placental calcification
The pro-inflammatory marker TNF-α was significantly increased in G3 compared to the control group (p = 0.016).
Original paper ↗Read more →Dietary Supplementation with 25-Hydroxyvitamin D3 on Reproductive Performance and Placental Oxidative Stress in Primiparous Sows during Mid-to-Late Gestation
Therefore, this study aimed to investigate the effects of supplementing 25-OH-D3 in the diet of primiparous sows on reproductive performance, antioxidant capacity, placental oxidative stress, nutrient transport, and inflammatory response during mid-to-late gestation.
Original paper ↗Read more →Effect of Vitamin D Supplementation on the Cerebral Placental Ratio in Pregnancy Complicated with Early Fetal Growth Restriction
The aim is to assess the relationship between CPR and vitamin D supplementation in fetuses with early FGR.
Original paper ↗Read more →Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
This study characterized metabolomic profiles of maternal adipose tissue, placenta, and cord blood in pre-pregnancy obesity and explored links to adverse pregnancy outcomes (APOs).
Original paper ↗Read more →Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome
Vitamin D deficiency has been implicated in the pathogenesis of several pregnancy complications attributed to impaired or abnormal placental function, but there are few clues indicating the mechanistic role of vitamin D in their pathogenesis.
Original paper ↗Read more →Placental Vitamin D Signalling, Fetal Development and Immune Tolerance: Full Evidence Review
Human placental and decidual studies assess vitamin D signalling, fetal development and immune tolerance, with clinical and source-access limits.
Read more →Early-pregnancy transcriptome signatures of preeclampsia: from peripheral blood to placenta
Several studies have linked maternal asthma, excess BMI, and low vitamin D status with increased risk of Preeclampsia (PE) development.
Original paper ↗Read more →Vitamin D deficiency during late pregnancy mediates placenta-associated complications
Aim of the study was to evaluate the relationship between vitamin D status and the occurrence of placenta-mediated complications (PMCs) in a population at high risk.
Original paper ↗Read more →COVID-19 during Gestation: Maternal Implications of Evoked Oxidative Stress and Iron Metabolism Impairment
The purpose of this study was to investigate, for the first time, the effects of COVID-19 infection during pregnancy with regard to the oxidative/antioxidant status in mothers’ serum and placenta, together with placental iron metabolism.
Original paper ↗Read more →Cohort profile: the Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada, 3-year and 5-year follow-up visits
We also investigated molecular mechanisms involved in the fetal programming of these later health outcomes.
Original paper ↗Read more →Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond
The effects of vitamin D on the production and action of several cytokines has been intensively investigated in recent years.
Original paper ↗Read more →Placental Vitamin D Metabolism and Transport: Full Evidence Review
Human placental experiments and pregnancy-trial samples clarify vitamin D uptake, local metabolism and limits of fetal-health interpretation.
Read more →25-Hydroxyvitamin D in pregnancy and genome wide cord blood DNA methylation in two pregnancy cohorts (MoBa and ALSPAC)
The aim of the study was to investigate whether maternal mid-pregnancy 25-hydroxyvitamin D concentrations are associated with cord blood DNA methylation.
Original paper ↗Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Long-term adherence and effects on grip strength and upper leg performance of prescribed supplemental vitamin D in pregnant and recently pregnant women of Somali and Swedish birth with 25-hydroxyvitamin D deficiency: a before-and-after treatment study
Muscular weakness and severe vitamin D deficiency is prevalent in Somali (veiled) pregnant women, Sweden.
Original paper ↗Read more →Maternal 25-Hydroxyvitamin D Deficiency Promoted Metabolic Syndrome and Downregulated Nrf2/CBR1 Pathway in Offspring
Metabolic syndrome is a disorder of energy use and storage, which is characterized by central obesity, dyslipidemia, and raised blood pressure and blood sugar levels.
Original paper ↗Read more →Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
The inverse relationship between 25(OH)D and parathyroid hormone (PTH) concentrations was examined to define the breakpoint at which PTH was maximally suppressed using a segmented regression analysis.
Original paper ↗Read more →Review: Influence of 25(OH)D Blood Concentration and Supplementation during Pregnancy on Preeclampsia Development and Neonatal Outcomes
Briefly, 25-hydroxyvitamin D (25(OH)D) plays an essential role in embryogenesis and the course of intra: and postnatal periods and is crucially involved in the functioning of the mother: placenta: fetus system.
Original paper ↗Read more →Sunlight exposed body surface area is associated with serum 25-hydroxyvitamin D (25(OH)D) level in pregnant Minangkabau women, Indonesia
This study was aimed to elucidate the association of sunlight exposed body surface area with serum 25(OH)D in pregnant Minangkabau women of Indonesia.
Original paper ↗Read more →The Association between Maternal 25-Hydroxyvitamin D Concentration during Gestation and Early Childhood Cardio-metabolic Outcomes: Is There Interaction with Pre-Pregnancy BMI?
Therefore, this study investigated the role of pBMI in the association between maternal 25OHD concentration and cardio-metabolic outcomes in 5-6 year old children.
Original paper ↗Read more →Total 25(OH)D Concentration Moderates the Association between Caffeine Consumption and the Alkaline Phosphatase Level in Pregnant Women
This study aimed to examine the effect of 25-hydroxyvitamin D (25(OH)D) concentration on the association between caffeine consumption and mineral metabolism in pregnant women.
Original paper ↗Read more →Original sources
Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit
Published in Ashley B et al (2022).
Publication details
Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. Ashley B et al. 2022. eLife. Volume 11; pages/article e71094. DOI: 10.7554/elife.71094.
Investigating a suitable model for the study of vitamin D mediated regulation of human placental gene expression
Published in Simner CL et al (2020).
Publication details
Investigating a suitable model for the study of vitamin D mediated regulation of human placental gene expression. Simner CL et al. 2020. The Journal of steroid biochemistry and molecular biology. Volume 199; pages/article 105576. DOI: 10.1016/j.jsbmb.2019.105576.
Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface
Published in Novakovic B et al (2009).
Publication details
Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. Novakovic B et al. 2009. The Journal of biological chemistry. Volume 284(22); pages/article 14838-14848. DOI: 10.1074/jbc.m809542200.
Vitamin D promotes human extravillous trophoblast invasion in vitro
Published in Chan SY et al (2015).
Publication details
Vitamin D promotes human extravillous trophoblast invasion in vitro. Chan SY et al. 2015. Placenta. Volume 36(4); pages/article 403-409. DOI: 10.1016/j.placenta.2014.12.021.
Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status
Published in Vestergaard AL et al (2024).
Publication details
Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status. Vestergaard AL et al. 2024. Nutrients. Volume 16(13); pages/article 2145. DOI: 10.3390/nu16132145.